Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation.

The research article studies the effects of a phenylbutazone paste on ponies, focusing on how it influences acute nonimmune inflammation. The paper confirms that the paste significantly reduces certain inflammation-related substances, potentially contributing to the clinical efficacy of the treatment schedule.

Research Methodology

• The study was designed around a 12-day treatment schedule during which 5 ponies were given a paste formulation of phenylbutazone (PBZ) orally and 5 were given a placebo paste in equivalent doses.
• On the 12th day, a mild, nonimmune inflammation was induced in each pony. This was done by inserting sterile, polyester sponge strips soaked in a 2% carrageenan solution under the skin on the ponies’ necks.
• The exudate or fluid resulting from the inflammation was collected at 4, 8, 12, and 24 hours by removing the sponges at each time interval.

Findings

• The research showed there were no significant differences in the concentration of protein and count of leukocyte cells in the exudate between the treatment groups. However, the group treated with PBZ exhibited significantly reduced concentrations of eicosanoids, compounds that have hormone-like effects.
• The reduction was seen specifically in 6-keto-prostaglandin F 1 alpha (at 4, 8, and 12 hours), thromboxane B2 (at 8, 12, and 24 hours) and bicyclic prostaglandin E2 (at 8 hours). The effect was most pronounced at the peak exudate concentrations of PBZ, specifically 8 and 12 hours.
• The findings also indicated that the PBZ was cleared more slowly from the exudate as compared to the plasma.

Additional Observations

• Changes in the surface skin temperature of the ponies were also recorded during the course of the study. This was done by measuring the temperature 1 cm below the base of the incision line through infra-red thermometry.
• Interestingly, the average increase in temperature was significantly lesser in ponies treated with PBZ as compared to those treated with the placebo.

Implications

• The results of the study suggest that PBZ may contribute to the clinical efficacy of the treatment schedule. By reducing the concentrations of key compounds involved in inflammation, this medication could potentially enhance the treatment outcomes for ponies undergoing procedures that produce acute nonimmune inflammation.